Literature DB >> 16274775

Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease.

Mohammad-Reza Movahed1, Mehrtash Hashemzadeh, M Mazen Jamal.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is a major risk factor for atherosclerosis. There is a controversy in literature about correlation between DM and atrial fibrillation. The goal of this study was to evaluate DM as a risk factor for atrial fibrillation or flutter using a very large database.
METHOD: Patient treatment files (PTF) containing discharge diagnoses were utilized using ICD-9 codes of inpatient treatment from Veterans Health Administration Hospitals (VAH). Patients with type II DM (ICD-9 code 250.0) (293,124) discharged from the VAH between 1990 and 2000. Non-matched controls without DM but with hypertension (552,624) were selected from the same PTF. By using multi-variate logistic regressions, the occurrence of atrial fibrillation, atrial flutter, CHF, CAD and LVH was compared.
RESULTS: Atrial fibrillations occurred in 43,674 (14.9%) DM patients vs. 57,077 (10.3%) in the control group (p<0.0001). Atrial flutter occurred in 11,852 (4%) of DM patients vs. 13,554 (2.5%) of the control group (p<0.0001). Using multi-variant analysis, DM remained independently associated with atrial fibrillation with an OR of 2.13, (95% CI: 2.10 to 2.16; p<0.0001) and flutter (OR 2.20, CI: 2.15 to 2.26; p<0.0001). Furthermore, CHF (OR 3.12, CI: 3.09 to 3.16; p<0.0001), LVH (OR 1.85, CI: 1.77 to 1.92; p<0.0001) and CAD (OR 2.39, CI: 2.34 to 2.44; p<0.0001) were also independently associated with DM.
CONCLUSION: This is the first large-scale study finding DM as a strong, independent risk for the occurrence of atrial fibrillation and flutter and other cardiovascular disease.

Entities:  

Mesh:

Year:  2005        PMID: 16274775     DOI: 10.1016/j.ijcard.2005.02.050

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  95 in total

1.  Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

Authors:  Omid Fatemi; Eugene Yuriditsky; Costas Tsioufis; Demetrios Tsachris; Timothy Morgan; Jan Basile; Thomas Bigger; William Cushman; David Goff; Elsayed Z Soliman; Abraham Thomas; Vasilios Papademetriou
Journal:  Am J Cardiol       Date:  2014-07-30       Impact factor: 2.778

Review 2.  Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Authors:  Rachel R Huxley; Kristian B Filion; Suma Konety; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-04-27       Impact factor: 2.778

Review 3.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

4.  Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Alanna M Chamberlain; Sunil K Agarwal; Marietta Ambrose; Aaron R Folsom; Elsayed Z Soliman; Alvaro Alonso
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

5.  Hyperoxia-induced cardiotoxicity and ventricular remodeling in type-II diabetes mice.

Authors:  Jennifer Leigh Rodgers; Eva Samal; Subhra Mohapatra; Siva Kumar Panguluri
Journal:  Heart Vessels       Date:  2017-12-05       Impact factor: 2.037

Review 6.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

7.  Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Naohito Tanabe; Toru Watanabe; Dawood Darbar; Dan M Roden; Shigeru Sasaki; Yoshifusa Aizawa
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

Review 8.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Authors:  Zoltán V Varga; Zoltán Giricz; Lucas Liaudet; György Haskó; Peter Ferdinandy; Pál Pacher
Journal:  Biochim Biophys Acta       Date:  2014-07-02

9.  Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

Authors:  Maryse Palardy; Anique Ducharme; Stanley Nattel; Jean-Claude Tardif; Michel White; Normand Racine; Karine Tétreault; Farida Dabouz; Mario Talajic; Denis Roy
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 10.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.